Rebecca Araujo

DocwireNews

Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, here are this week&rsquo;s top headlines:<ul>
<li>VIDEO: <a href="https://www.docwirenews.com/docwire-pick/dr-carolyn-kay-on-the-importance-of-identifying-hpv-patients-at-higher-risk-for-cervical-cancer/">Dr. Carolyn Kay on Identifying HPV+ Patients at Higher Risk for Cervical Cancer</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/astro-guidelines-for-ebrt-in-liver-cancer-key-takeaways/">ASTRO Guideline for EBRT in Liver Cancer: Key Takeaways</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/tailored-strategies-can-up-depression-referrals-in-breast-cancer/">Tailored Strategies Can Up Depression Referrals in Breast Cancer</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/psychological-distress-more-likely-in-young-adult-cancer-survivors/">Psychological Distress More Likely in Young Adult Cancer Survivors</a></li>
</ul>Keep reading for the breakdown on these top stories.RELATED: Last Week&rsquo;s Round-Up: <a href="https://www.docwirenews.com/weekly-roundup/oncology-news-round-up-cns-tumors-in-children-not-linked-to-maternal-contraception/">Is Maternal Contraception Related to Pediatric CNS Tumors?</a><h2>Dr. Carolyn Kay: Identifying High-Risk HPV</h2>Editors sat down with Dr. Carolyn Kay, an OB/GYN physician, about results from the IMPACT trial, which demonstrated that <a href="https://www.roche.com/media/releases/med-cor-2020-09-16.htm">Roche&rsquo;s CINtec PLUS Cytology</a>, when used as a triage test for high-risk human papillomavirus (HPV), showed significantly higher sensitivity in detecting cervical pre-cancers in HPV-positive women compared to Pap cytology.&ldquo;The objective of the study was to compare the diagnostic performance of the biomarker technology to Pap cytology for the triage of high-risk HPV positive results,&rdquo; said Dr. Kay. &ldquo;[These data] formed the basis of the FDA approval of our dual biomarker cytology test, commercially known as CINtec PLUS.&rdquo;https://www.docwirenews.com/docwire-pick/dr-carolyn-kay-on-the-importance-of-identifying-hpv-patients-at-higher-risk-for-cervical-cancer/RELATED VIDEO: <a href="https://www.docwirenews.com/videos/kol-videos/womens-health-expert-on-the-impact-of-unplanned-pregnancies/">Women&rsquo;s Health Expert on the Impact of Unplanned Pregnancy</a><h2>ASTRO Guideline for EBRT in Liver Cancer</h2>The&nbsp;<a href="https://www.astro.org/">American Society for Radiation Oncology</a>&nbsp;(ASTRO) released a new guideline regarding external beam radiation therapy (EBRT) for primary liver cancer. This is the first ASTRO guideline regarding primary liver cancers, and it was published in&nbsp;<a href="https://www.practicalradonc.org/article/S1879-8500(21)00233-2/fulltext">Practical Radiation Oncology</a>.<ul>
<li>EBRT is&nbsp;strongly recommended&nbsp;as:</li>
</ul><ul>
<li>a potential first-line treatment in liver-confined hepatocellular carcinoma (HCC) in patients ineligible for curative therapy</li>
<li>consolidative therapy after incomplete response to previous liver-directed therapies</li>
<li>a salvage option for local recurrence.</li>
</ul><ul>
<li>EBRT is&nbsp;conditionally recommended:</li>
</ul><ul>
<li>for patients with liver-confined multifocal or unresectable HCC</li>
<li>for patients with macrovascular invasion, in sequence with systemic or catheter-based therapies</li>
<li>as a palliative therapy for symptomatic primary HCC and/or macrovascular tumor thrombi</li>
<li>as a bridge to transplant or before surgery in selected patients</li>
<li>as an adjuvant therapy for resected intrahepatic cholangiocarcinoma (IHC) with high-risk features</li>
</ul>https://www.docwirenews.com/docwire-pick/hem-onc-picks/astro-guidelines-for-ebrt-in-liver-cancer-key-takeaways/RELATED: <a href="https://www.docwirenews.com/hematology-oncology/astro-ebrt-underused-in-liver-cancer-patients-awaiting-transplant/">EBRT Underused in Liver Cancer Patients Awaiting Transplant</a><h2>Tailored Strategies Can Up Depression Referrals in Breast Cancer</h2>For patients with newly diagnosed breast cancer, tailored strategies for implementation of routine depression screening result in a greater proportion of referrals to behavioral care, according to a study published in JAMA.Researchers examined the effectiveness of an implementation strategy-guided depression screening program in a trial conducted at six medical centers with 1,436 patients diagnosed with new primary breast cancer. The centers were randomly assigned to either tailored implementation strategies (three sites; 744 patients) or education-only (three sites; 692 patients). The program consisted of 9-item Patient Health Questionnaire screening and algorithm-based scoring and referral to behavioral health services; at tailored intervention sites, clinical teams received program education, audit, and feedback of performance data and implementation facilitation.The researchers found that 7.9% and 0.1% of patients at tailored sites and education-only sites, respectively, were referred. Referrals to a behavioral health clinician were completed by 44 of 59 (75%) and one of one patient at the intervention and education-only sites, respectively. Patients at tailored sites had significantly fewer outpatient visits in medical oncology; no differences were seen in utilization of primary care, urgent care, or emergency department visits.https://www.docwirenews.com/docwire-pick/hem-onc-picks/tailored-strategies-can-up-depression-referrals-in-breast-cancer/RELATED: <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/psychological-distress-more-likely-in-young-adult-cancer-survivors/">Psychological Distress More Likely in Young Adult Cancer Survivors</a><h2>Want to see more oncology news?</h2>Check out last week&rsquo;s <a href="https://www.docwirenews.com/weekly-roundup/oncology-news-round-up-cns-tumors-in-children-not-linked-to-maternal-contraception/">Round-Up</a>, and be sure to keep up with the latest oncology news and cancer research here on DocWire, updated daily!

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Oncology News Round-Up: Detecting High-Risk HPV; New EBRT Guidelines

Oncology

Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, here are this week’s top headlines: ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe